Fractyl Health reports Q4 results

* Fractyl Health press release [https://seekingalpha.com/pr/20449872-fractyl-health-reports-fourth-quarter-and-full-year-2025-financial-results-and-business] (GUTS [https://seekingalpha.com/symbol/GUTS]): Q4 Net Loss: For the quarter ended December 31, 2025, Fractyl reported a net loss of $43.7 million, compared to $25.0 million for the same period in 2024.
* Adjusted EBITDA: Adjusted EBITDA was negative $21.2 million for the quarter ended December 31, 2025, compared to negative $22.1 million for the same period in 2024. The decrease was primarily due to the decrease in operating expenses.
* Cash Position: As of December 31, 2025, Fractyl had approximately $81.5 million in cash and cash equivalents. Based on current business plans, the Company believes its cash position as of December 31, 2025, combined with $4.1 million subsequent proceeds from warrant exercises received in January 2026, will fund operations into early 2027.

MORE ON FRACTYL HEALTH

* Fractyl Health: Unreasonably Low Market Expectations Create A Trading Opportunity Towards 2026 Catalysts [https://seekingalpha.com/article/4865027-fractyl-health-low-market-expectations-create-trading-opportunity-with-catalysts]
* Fractyl Health, Inc. (GUTS) Discusses REMAIN-1 Midpoint Cohort Results on Revita for Weight Maintenance After GLP-1 Discontinuation Transcript [https://seekingalpha.com/article/4864016-fractyl-health-inc-guts-discusses-remainminus-1-midpoint-cohort-results-on-revita-for-weight]
* Quant snapshot: AAR, Noah Holdings lead strong buys as Blaize, Fractyl Health lag [https://seekingalpha.com/news/4566972-quant-snapshot-aar-noah-holdings-lead-strong-buys-as-blaize-fractyl-health-lag]
* Fractyl Health plummets on data for Revita for weight loss maintenance [https://seekingalpha.com/news/4544236-fractyl-health-plummets-data-revita-weight-loss-maintenance]
* Seeking Alpha’s Quant Rating on Fractyl Health [https://seekingalpha.com/symbol/GUTS/ratings/quant-ratings]